An article on our latest research regarding the US market for electrophysiology and cardiac ablation devices was published on Med Device Online written by iData Research Analyst Andrew Bieg, and CEO Kamran Zamanian. Click Here to View the Article on Med Device Online.
Scientists have developed a simple, low-cost spinal fusion device to reduce chronic back pain that may help avoid the need for more invasive surgery and painful bone grafts. Researchers anticipate the innovative medical device, Thru-Fuze, will transform spinal fusion surgery, which is used when conservative therapies such as physical therapy, medication and injections have failed. read more}
Will you be attending this year’s symposium? Let us know and you will be eligible for an exclusive discount on our latest Interventional Cardiology Device Market Research Report. This year, the symposium will focus on a comprehensive approach to the percutaneous management of structural heart disease and coronary and peripheral vascular disease. read more}
Price competition and the prevalence of minimally invasive surgeries (MIS) has created a high demand for surgical cameras. MIS surgeries are cost-effective as they can save a hospital between €2,000 and €15,000 per patient due to the reduced operating times, shorter hospital stays, and lower infection and complication rates. read more}
According to a new series of reports on the U.S. market for dental prosthetics and CAD/CAM devices by iData Research, the introduction of inexpensive CAD/CAM devices is resulting in a greater emphasis on competitive pricing due to new market entrants. This has been quite pronounced within the intraoral scanner market where there is a great potential for growth. Competitive pricing has also been prevalent for the CAD/CAM disc market. read more}
According to a recently published retrospective case-control study in the latest Spine journal, the use of laparoscopy with an anterior approach did not increase surgical time and decreased intraoperative blood loss and the need for intraoperative red blood cell transfusions in patients treated for primary malignant sacral tumors. read more}